Sarms Powder Rad140 (Testolone) CAS 1182367-47-0 100% Safely Pass Customs
|FOB Unit Price:||US $15 US $12|
|Purchase Qty. (gram)||FOB Unit Price|
|Payment Terms:||T/T, Western Union, Money Gram, bitcoin|
- Model NO.: 1182367-47-0
- Customized: Customized
- Suitable for: Adult
- Purity: >99%
- Transport Package: Foilbag
- Origin: China
- Powder: Yes
- Certification: GMP, ISO 9001, USP, BP
- State: Powder
- Trademark: yuancheng
- Specification: 1gram/foilbag
Product Name: RAD-140
Package: 100 g/foil bag
Storage: keep cool and dry,away from light
Transportation: By air or by courier
RAD140 is a nonsteroidal selective androgen receptor modulator, or SARM, that resulted from an internal drug discovery program that began in 2005.
RAD 140 is a SARM that is designed to act as if the tissues of the body are getting a good dose of testosterone without the unwanted side effects of anabolic steroids. It has been shown to enhance speed, stamina and endurance during workouts as well as increase muscular gains within shorter periods of time
RAD140 has demonstrated potent anabolic activity on muscle and bone in preclinical studies and has completed 28day preclinical toxicology studies in both rats and monkeys. Because of its high anabolic efficacy, receptor selectivity, potent oral activity and long duration halflife, we believe that RAD140 has clinical potential in a number of indications where the increase in lean muscle mass and/or bone density is beneficial, such as treating the weight loss due to cancer cachexia, muscle frailty and osteoporosis, and also in the treatment of breast cancer.
The Recommended Dosage for RAD140
Experts are still fine-tuning how much the ideal dosage is for RAD 140 SARM to maximize its benefits, particularly increasing lean body mass. The ongoing scientific studies are still verifying which among 0.3, 3 and 30 milligrams of RAD 140 SARM per day can help achieve the best results.
The recommended dosages of RAD140 vary from 20 to 30 milligrams (mgs) per day, and the optimal cycle duration is 12-14 weeks.
As a research chemical, RAD140 should come in liquid form to be taken orally. It is important to drop the liquid directly into the mouth, as it may stick to the walls of the glass if mixed with liquids. After dropping it into the mouth, you can chase it down with water or grape juice. Due to the relatively long half life, RAD140 can be dosed just once per day, and there is no need to be taking it several times per day.
Possible Side Effects of RAD140
Researchers point out that they still haven't come across any adverse side effects that RAD 140 SARM can cause when used.
RAD140 compared to testosterone
Testosterone is considered as the perfect comparison template in terms of androgenic and anabolic effects of different compounds, where a ratio of 100:100 is the baseline. In this regard, RAD140 has an impressive ratio of 90:1. This means that it is almost as anabolic as testosterone is, but it lacks the androgenic effects, which is a very positive thing, since most of the side effects associated to steroid use come from their androgenic effects.
In addition to that, it has been determined that you would need 40% more of testosterone for the same muscle growth as with RAD140, and yet it would take 60 times more of RAD140 to even start showing any prostate related side effects.
Regarding the affinity to androgen receptors, studies have shown that it has approximately 30% of the affinity seen with testosterone, and almost the same affinity as dihydrotestosterone (DHT).
Hot on Sale
acts by entering nucleoside pools,
significantly increasing levels of adenosine during periods of ATP breakdown
medical prescription for prevention of cachexia, atrophy,
and sarcopenia and for Hormone or Testoserone Replacement Therapy.
A growth hormone secretagogue, treatment of obesity,
a promising therapy for the treatment of frailty in the elderly
|1165910-22-4||pharmacological profile similar to that of enobosarm, Ostarine,MK-2866|
|GW1516||317318-70-0||For obesity, diabetes, dyslipidemia and cardiovascular disease|
|Andarine(S4)||401900-40-0||partial agonist, intended mainly for treatment of benign prostatic hypertrophy|
under development at The Scripps Research Institute (TSRI),
increases the level of metabolic activity in skeletal muscles of mice
|1182367-47-0||New generation for gaining mass and cutting edges|
|YK11||431579-34-9||YK11: a SARM and myostatin inhibitor in one|